ShangPharma Corp. (SHP) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts SHP Hot Sheet
Join SI Premium – FREE
ShangPharma Corp. (NYSE: SHP) reported Q3 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $28.84 million versus the consensus estimate of $28.91 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Li Auto Inc. (LI) Misses Q2 EPS by 2c; misses on guidance
- Synopsys (SNPS) Tops Q3 EPS by 24c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
